Skip to main content
Clinical Trials/NL-OMON21400
NL-OMON21400
Not yet recruiting
Not Applicable

Functional outcome and quality of life in adult congenital heart disease patients with prosthetic valves (PROSTAVA-study).

etherlands Heart FoundationUniversity Medical Center GroningenICI0 sites600 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prosthetic Valves
Sponsor
etherlands Heart FoundationUniversity Medical Center GroningenICI
Enrollment
600
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
etherlands Heart FoundationUniversity Medical Center GroningenICI

Eligibility Criteria

Inclusion Criteria

  • Adult Congenital Heart Disease patients with a prosthetic heart valve (both homografts,
  • heterografts and mechanical valves in aortic, mitral, pulmonary or tricuspid position) who are included in the CONCOR database and who give informed consent for the study.

Exclusion Criteria

  • Inability to comply with primary endpoint measures (completion of quality of life questionary, VO2max). Pregnant patients will not be included, they may be included \> 3 months after pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials